Argireline

Argireline (Acetyl Hexapeptide-3) is a synthetic hexapeptide applied topically in cosmetic formulations to reduce the appearance of expression lines. It is proposed to partially inhibit the SNAP-25 component of the SNARE protein complex, attenuating the strength of muscle contractions that drive dynamic wrinkle formation. Controlled human trials have demonstrated statistically significant reductions in wrinkle depth with repeated topical application compared to placebo, representing some of the stronger human evidence available for a cosmetic peptide. Argireline is classified as a cosmetic ingredient, not a drug; it has not been evaluated by the FDA for efficacy and existing evidence is limited to cosmetic endpoints in small-to-medium trials. Argireline concentration and use: in published cosmetic studies, argireline is used at concentrations of 5–10% in topical formulations, applied to areas of dynamic expression lines such as forehead and periorbital regions. The mechanism of action — partial SNARE complex inhibition rather than complete neurotoxin-class blockade — means the effect is typically described as softening expression line depth rather than eliminating muscle movement. Results in human studies develop over 4–8 weeks of twice-daily application. Argireline vs SNAP-8: SNAP-8 (Acetyl Octapeptide-3) is a longer structural derivative of argireline developed to extend SNARE complex competitive inhibition further along the docking sequence, with manufacturer-sponsored data suggesting improved potency at lower concentrations. The key difference in evidence quality: argireline has independent peer-reviewed human trial data, while SNAP-8 data originates primarily from manufacturer-sponsored studies not indexed in standard biomedical literature. Both are topical cosmetic ingredients and neither carries regulatory drug approval. For cosmetic peptides with more systemic research profiles — including GHK-Cu, which has several decades of independent research — the PeptideBase skin and joint peptides directory covers the broader landscape.